Application of mathematical models in predicting drug dosage and its efficacy

The purpose of the research is to form a comprehensive understanding of how mathematical models are used to interpret complex dynamics related to the distribution, metabolism and excretion of drugs in the human body. The use of mathematical models to predict the required dose of drug prescriptions and establish its effectiveness means a paradigm shift in the field of pharmacology.

Methods. The methodology used in this study was aimed at identifying and analytically reviewing articles that correspond to the objectives of the study. The publications included in the analysis were analyzed and data extracted, focusing on key information such as the mathematical modeling methodology used, the exact predicted treatment effects, the populations studied, long-term prognostic effects, and the assessment of the use of various drug dosing regimens.

Results. In total, 12 publications were analyzed, which used four different methodologies: models with the effects of several different conditions, models that take into account the occurrence of various discrete events, models based on the effects of informative signs taking into account the physiology of individuals, as well as survival models and generalized linear models.

Conclusion. The conducted study of the current state of mathematical modeling in medical research for the purpose of comparative effectiveness is intended for practicing scientists and doctors in conducting further research and introducing innovations. Despite the challenges, the potential impact of these models aimed at bridging the gap between the controlled clinical environment and the real health context is undeniable. The use of mathematical modeling methods to predict the dosage of medicines will improve the quality and effectiveness of personalized medical appointments in the coming years.

1. Hartmanshenn C., Scherholz M., Androulakis I.P. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. Journal of Pharmacokinetics and Pharmacodynamics. 2016;(43):481–504.

2. Marsousi N., Desmeules J.A., Rudaz S., Daali Y. Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine. J. Pharm. Sci. 2017;106(9):2380–2391.

3. Krauss M., Tappe K., Schuppert A., Kuepfer L., Goerlitz L. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations. PLoS One. 2015;10(10):0139423. https://doi.org/10.1371/journal.pone.0139423

4. Fan C., Basharat Z., Mah K., Wei C.R. Computational approach for drug discovery against Gardnerella vaginalis in quest for safer and effective treatments for bacterial vaginosis. Sci. Rep. 2024;14(1):17437. https://doi.org/10.1038/s41598-024-68443-2

5. Djuris J., Cvijic S., Djekic L. Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration. Pharmaceuticals (Basel). 2024:17(2):177. https://doi.org/10.3390/ph17020177

6. Wang Y., Zhu H., Madabushi R., Liu Q., Huang S.M., Zineh I. Model-informed drug development: Current US regulatory practice and future considerations. Clin. Pharmacol. Ther. 2019;105(4):899–911. https://doi.org/10.1002/cpt.1363

7. Cvijić S., Ignjatović J., Parojčić J., Ibrić S. The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development. Arh. Farm. 2021;71:318–335. https://doi.org/10.5937/arhfarm71-32479

8. Kesisoglou F., Chung J., van Asperen J., Heimbach T. Physiologically based absorption modeling to impact biopharmaceutics and formulation strategies in drug development-industry case studies. J. Pharm. Sci. 2016;105(9):2723–2734. https://doi.org/10.1016/j.xphs.2015.11.034

9. Abbiati R.A., Manca D. A modeling tool for the personalization of pharmacokinetic predictions. Comput. Chem. Eng. 2016;91:28–37. https://doi.org/10.1016/j.compchemeng.2016.03.008

10. Dar K.B., Bhat A.H., Amin S., Hamid R., Anees S., Anjum S., Reshi B.A., Zargar M.A., Masood A., Ganie S.A. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect. Curr. Top. Med. Chem. 2018;18(31):2702–2719.

11. Singh K., Bhushan B., Singh B. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling. Curr. Comput. Aided. Drug. Des. 2024;20(5):697–710. https://doi.org/10.2174/1573409920666230914123005

12. Razia I.T., Kanwal A., Riaz H.F., Malik A., Ahsan M., Khan M.S., Raza A., Sabir S., Sajid Z., Khan M.F., Tahir R.A., Sehgal S.A. Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery. Curr. Top. Med. Chem. 2023;23(30):2844–2862.

13. Hasan R., Alsaiari A.A., Fakhurji B.Z., Molla M.H.R., Asseri A.H., Sumon A.A., Park M.N., Ahammad F., Kim B. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process. Molecules. 2022;27(13):4169.

14. Atanasov A.G., Zotchev S.B., Dirsch V.M., Orhan I.E., Banach M., Rollinger J.M., Barreca D., Weckwerth W., Bauer R., Bayer E.A., et al. Natural Products in Drug Discovery: Advances and Opportunities. Nat. Rev. Drug. Discov. 2021;20:200–216.

15. Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., et al. Discovery and Resupply of Pharmacologically Active Plant-Derived Natural Products: A Review. Biotechnol. Adv. 2015;33:1582–1614.

16. Li C.Q., Lei H.M., Hu Q.Y., Li G.H., Zhao P.J. Recent Advances in the Synthetic Biology of Natural Drugs. Front. Bioeng. Biotechnol. 2021;9:640. https://doi.org/10.3389/fbioe.2021

17. Rudrapal M., Khairnar S.J., Jadhav A.G. Drug Repurposing (DR): An Emerging Approach in Drug Discovery. In: Drug Repurposing. IntechOpen; 2020. 234 p.

18. Biala G., Kedzierska E., Kruk-Slomka M., Orzelska-Gorka J., Hmaidan S., Skrok A., Kaminski J., Havrankova E., Nadaska D., Malik I. Research in the Field of Drug Design and Development. Pharmaceuticals (Basel). 2023;16(9):1283.

19. Gunnarsson E.B., Kim S., Choi B., Schmid J.K., Kaura K., Lenz H.J., Mumenthaler S.M., Foo J. Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework. PLoS. Comput. Biol. 2024;20(8):e1012256.

20. Ncube N.B., Tukulula M., Govender K.G. Leveraging computational tools to combat malaria: assessment and development of new therapeutics. J. Cheminform. 2024;16(1):50.